0 Bedömningar
ID

26167

Beskrivning

Study ID: 101468/196 Clinical Study ID: 101468/196 Study Title: 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00650104 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Parkinson DiseaseA Long-Term, Open-Label Continuation Study of Once Daily Adminstration of Ropinirole CR Tablets to Patients with Parkinson's Disease Who Completed the Previous Ropinirole CR Studies - 167 & 164 End of Re-Enrollment Titration Period

Nyckelord

Versioner (1)
  1. 2017-10-10 2017-10-10 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

10 oktober 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC-ND 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

    Engelsk

    End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

    1 Formulär  
    Patient Information
    Beskrivning

    Patient Information

    Alias
    UMLS CUI-1
    C1955348
    Patient No.
    Beskrivning

    Patient Number

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C1830427
    Date of Visit
    Beskrivning

    Date of Visit

    Datatyp

    date

    Måttenheter
    • dd-mmm-yyyy
    Alias
    UMLS CUI [1]
    C1320303
    dd-mmm-yyyy
    End of Re-Enrollment Titration Period
    Beskrivning

    End of Re-Enrollment Titration Period

    Alias
    UMLS CUI-1
    C1516879
    UMLS CUI-2
    C1272693
    UMLS CUI-3
    C2983683
    Dose of Study Medication prescribed for Maintenance period:
    Beskrivning

    Dosage of study drug

    Datatyp

    float

    Måttenheter
    • mg/d
    Alias
    UMLS CUI [1,1]
    C0178602
    UMLS CUI [1,2]
    C0304229
    mg/d
    At which week did Titration end?
    Beskrivning

    End Date of Titration

    Datatyp

    float

    Måttenheter
    • week
    Alias
    UMLS CUI [1,1]
    C2983683
    UMLS CUI [1,2]
    C0806020
    week
    Investigator Signature
    Beskrivning

    Investigator Signature

    Alias
    UMLS CUI-1
    C2346576
    To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Signature
    Beskrivning

    Signature

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C1519316
    To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Print Name:
    Beskrivning

    Investigator's Name

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C2826892
    Date
    Beskrivning

    Date of Report

    Datatyp

    date

    Måttenheter
    • dd-mmm-yyyy
    Alias
    UMLS CUI [1]
    C1302584
    dd-mmm-yyyy
    Tillbaka till toppen

    Similar models

    End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

    1 Formulär
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Patient Information
    C1955348 (UMLS CUI-1)
    Patient Number
    Item
    Patient No.
    text
    C1830427 (UMLS CUI [1])
    Date of Visit
    Item
    Date of Visit
    date
    C1320303 (UMLS CUI [1])
    Item Group
    End of Re-Enrollment Titration Period
    C1516879 (UMLS CUI-1)
    C1272693 (UMLS CUI-2)
    C2983683 (UMLS CUI-3)
    Dosage of study drug
    Item
    Dose of Study Medication prescribed for Maintenance period:
    float
    C0178602 (UMLS CUI [1,1])
    C0304229 (UMLS CUI [1,2])
    End Date of Titration
    Item
    At which week did Titration end?
    float
    C2983683 (UMLS CUI [1,1])
    C0806020 (UMLS CUI [1,2])
    Item Group
    Investigator Signature
    C2346576 (UMLS CUI-1)
    Signature
    Item
    To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Signature
    text
    C1519316 (UMLS CUI [1])
    Investigator's Name
    Item
    To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Print Name:
    text
    C2826892 (UMLS CUI [1])
    Date of Report
    Item
    Date
    date
    C1302584 (UMLS CUI [1])
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial